Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. D Other Notice of Sales of Unregistered Securities
  2. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
  3. 4 Open-market sale See remarks sold 244 shares at $11.51 ($2,808)
  4. 4 Open-market sale Chief Financial Officer sold 294 shares at $11.51 ($3,384)
  5. 4 Open-market sale President, R&D sold 977 shares at $11.51 ($11,245)
  6. 4 Open-market sale Chief Legal Officer sold 294 shares at $11.51 ($3,384)
  7. 424B7 Offering Prospectus
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 4 Open-market sale See remarks sold 1,354 shares at $6.03 ($8,165)
  11. 4 Open-market sale Chief Financial Officer sold 1,697 shares at $6.03 ($10,233)
  12. 4 Open-market sale President, R&D sold 3,451 shares at $6.03 ($20,810)
  13. 4 Open-market sale Chief Legal Officer sold 1,632 shares at $6.03 ($9,841)
  14. 8-K Event Regulation FD disclosure · Other events
  15. SC 13G Stake Amended Statement of Ownership
  16. 4 Grant or award President and CEO acquired 1,662 shares (grant or award)
  17. 4 Open-market sale President, R&D sold 648 shares at $8.38 ($5,430)
  18. 4 Open-market sale See remarks sold 244 shares at $8.38 ($2,045)
  19. 4 Open-market sale Chief Financial Officer sold 294 shares at $8.38 ($2,464)
  20. 4 Open-market sale Chief Legal Officer sold 294 shares at $8.38 ($2,464)

Page 14 of 28 · 556 filings